<DOC>
	<DOCNO>NCT02483260</DOCNO>
	<brief_summary>To provide intravenous ribavirin therapeutic option patient probable suspected case viral hemorrhagic fever , specifically Crimean-Congo hemorrhagic fever Lassa fever .</brief_summary>
	<brief_title>Intravenous Ribavirin Protocol Treat Individuals With Viral Hemorrhagic Fever</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Hemorrhagic Fevers , Viral</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>Meets case definition probable suspected case CCHF LF Must DoDaffiliated personnel include active reserve component service member , US civilian employee , contractor , US personnel , dependent well allied military force local national grant access medical facility Is least 18 year age ( 17 , active military ) great 65 year age Has blood sample draw type crossmatch order transfusion Has hemoglobin great equal to10 g/dL start IV ribavirin Agrees collection require specimen Agrees report adverse event duration protocol Agrees followup visit donate blood urine specimen Day 14 ( ±2 day ) first dose IV ribavirin agree followup visit anemia medical condition require attend physician Female patient childbearing potential must pregnancy test . Patient counsel concern risk IV ribavirin versus treatment pregnancy test positive . If test negative , patient agrees take precaution avoid pregnancy treatment 7 month treatment . Male patient agrees intercourse pregnant woman take precaution avoid produce pregnancy treatment 7 month ribavirin treatment . Female patient agrees breastfeed treatment 7 month ribavirin treatment • Has know intolerance ribavirin . Is irreversibly ill presentation , define presence profound shock ( shock respond supportive therapy within 3 hour admission ) . Has hemoglobin le 10 g/dL correct 10 g/dL initiation IV ribavirin Has history hemoglobinopathy ( ie , sicklecell anemia thalassemia major ) . Has history autoimmune hepatitis . Has serum calculate creatinine clearance &lt; 30 mL/min . History second third degree heart block sick sinus syndrome without pacemaker capability pacemaker placement WolfeParkinsonWhite Syndrome . A sinus bradycardia le 40 beat per minute ( see ) . Is currently treat didanosine ( ddI ) . ddI must discontinue start IV ribavirin . Relative At principal investigator 's ( PI ) discretion , individual may treat IV ribavirin , caution , one criterion present . A positive pregnancy test . The patient inform risk benefit treatment IV ribavirin versus ribavirin treatment CCHF ( generally associate high mortality ) severe case Lassa fever ( high mortality rate ) versus mild case Lassa fever ( low mortality rate ) . A New York Heart Association cardiac functional capacity Class II great atherosclerotic heart disease ( ASHD ) congestive heart failure ( CHF ) . Known cardiac defect may predispose subject bradyarrhythmias , second third degree heart block sick sinus syndrome without pacemaker , capability pacemaker placement , need . Sinus bradycardia 4149 beat per minute , individual know low rest heart rate relate physical conditioning . Use drug know result bradyarrhythmias ( certain beta blocker calcium channel blocker , digoxin , well clonidine , cholinesterase inhibitor , lithium ) . History gout</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>